44.75 USD
↘ 0.61 (1.34%)AT CLOSE (11:59 AM EDT)
Vericel Corporation
VCELNASDAQ • USD
44.73
↘ 0.02 (0.04%)
POST MARKET (AS OF 07:34 PM EDT)
Post Market
AS OF 07:34 PM EDT
44.73
↘ 0.02 (0.04%)
Market: CLOSED
Vericel Corporation (VCEL) is currently trading at $44.72. The technical outlook is "Sell" and the fundamental picture shows "Neutral". Key drivers include a robust Altman Z-Score and a bullish Golden Cross on the moving averages. Furthermore, VCEL is currently richly valued, trading at a premium to sector peers across key valuation metrics.
Technical & fundamental data as of Aug 6, 2026.
Open?$45.18
High?$45.40
Low?$44.33
Prev. Close?$45.36
Volume?334.7K
Avg. Volume?602.3K
VWAP?$44.63
Rel. Volume?0.56x
Bid / Ask
Bid?$30.07 × 300
Ask?$50.51 × 100
Spread?$20.44
Midpoint?$40.29
Valuation & Ratios
Market Cap?2.3B
Shares Out?51.2M
Float?47.2M
Float %?92.4%
P/E Ratio?95.90
P/B Ratio?6.28
EPS?$0.47
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
Employees
398
Market Cap
2.3B
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
1997-02-04
Address
25 BLUE SKY DRIVE
BURLINGTON, MA 01803
Phone: (617) 588-5555
BURLINGTON, MA 01803
Phone: (617) 588-5555
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?40
Z-Score?100
Momentum?85
Short Sent.?39
Piotroski F-Score?4/9Mixed
Altman Z-Score?10.67Safe
Confidence?62%Moderate
Short InterestHigh
Short % of Float?9.76%Elevated
Short Interest?4.6M
Days to Cover?9.1
Free Float47.2M
Avg Daily Volume508.4K
Settlement Date2026-07-15
Financial Health
Current Ratio?5.04Strong
Quick Ratio?4.69Strong
Cash Ratio?2.39Strong
Debt/Equity?0.00Low
ValuationRICHLY VALUEDvs 1 peers + S&P 500
Score39/100
P/E?95.9PRICEY▾
Peers100
S&P3
P/B?6.28FAIR▾
Peers100
S&P29
P/S?7.58HIGH▾
Peers100
S&P15
P/FCF?37.7PRICEY▾
Peers100
S&P19
EV/EBITDA?70.5HIGH▾
Peers100
S&P3
EV/Sales?7.17HIGH▾
Peers100
S&P19
Returns & Efficiency
ROE?6.6%FAIR▾
Peers50
S&P22
ROA?4.8%FAIR▾
Peers50
S&P44
Cash Flow & Enterprise
FCF?$61.7M
Enterprise Value?$2.2B
Fundamentals ratios updated end of day